Notably, TβMCA is an established antagonist of FXR, a receptor increasingly recognised for its role in metabolic regulation and pancreatic cancer biology, highlighting a potentially relevant mechanistic axis in our study [30]. The gene discussed is NR1H4; the disease is pancreatic neoplasm.